Tech Forum: Close to the Heart - Biomaterial Developed to Serve Vascular Applications

dsm-firmenich Biomedical has developed TheraPEA™ polyester amide material platform for drug delivery. This class of biomaterials are based on naturally occurring amino acids linked with hydrocarbon spacers to provide optimal thermal and mechanical properties. TheraPEA™ technology demonstrates high mechanical coating integrity, unique biodegradation properties, biocompatibility and drug release kinetics. - features of particular interest for drug-eluting cardiovascular stent application.
TheraPEA™ polymers can be customized to match specific drug or therapy requirements which makes them successful for extended-release applications beyond cardiovascular DES.